These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 17699534

  • 1. Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccine.
    Mixer RE, Jamrozik K, Newsom D.
    J Epidemiol Community Health; 2007 Sep; 61(9):797-801. PubMed ID: 17699534
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Perspectives on the Measles, Mumps and Rubella Vaccination among Somali Mothers in Stockholm.
    Jama A, Ali M, Lindstrand A, Butler R, Kulane A.
    Int J Environ Res Public Health; 2018 Nov 01; 15(11):. PubMed ID: 30388799
    [Abstract] [Full Text] [Related]

  • 4. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
    Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E.
    PLoS One; 2014 Nov 01; 9(2):e89361. PubMed ID: 24586717
    [Abstract] [Full Text] [Related]

  • 5. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Carryn S, Feyssaguet M, Povey M, Di Paolo E.
    Vaccine; 2019 Aug 23; 37(36):5323-5331. PubMed ID: 31345639
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M, Pattison HM.
    Br J Gen Pract; 2000 Dec 23; 50(461):969-71. PubMed ID: 11224968
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.
    Pediatr Infect Dis J; 2008 Aug 23; 27(8):724-30. PubMed ID: 18600190
    [Abstract] [Full Text] [Related]

  • 9. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
    Nolan T, McIntyre P, Roberton D, Descamps D.
    Vaccine; 2002 Dec 13; 21(3-4):281-9. PubMed ID: 12450703
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ.
    Vaccine; 2018 Feb 01; 36(6):818-826. PubMed ID: 29317117
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants.
    Nic Lochlainn LM, Woudenberg T, van Lier A, Zonnenberg I, Philippi M, de Melker HE, Hahné SJM.
    Vaccine; 2017 Oct 13; 35(43):5828-5834. PubMed ID: 28923422
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.
    Wellington K, Goa KL.
    Drugs; 2003 Oct 13; 63(19):2107-26. PubMed ID: 12962524
    [Abstract] [Full Text] [Related]

  • 18. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.
    Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.
    Pediatr Infect Dis J; 2005 Dec 13; 24(12):1083-8. PubMed ID: 16371870
    [Abstract] [Full Text] [Related]

  • 19. The impact of maternal measles-rubella immunization on the 12-month-old infant's immune response to measles-mumps-rubella vaccine immunogenicity.
    Saffar MJ, Ajami A, Khalilian AR, Saffar H.
    Eur J Clin Microbiol Infect Dis; 2009 Jul 13; 28(7):845-7. PubMed ID: 19229565
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.